Previous close | 28.80 |
Open | 28.80 |
Bid | 31.00 |
Ask | 40.25 |
Strike | 107.00 |
Expiry date | 2024-05-31 |
Day's range | 28.80 - 28.80 |
Contract range | N/A |
Volume | |
Open interest | 22 |
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
Moderna stock is on the rise again as investors focus on the potential need for a bird flu vaccine. Is MRNA stock a buy right now?
Moderna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.